Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/36473
COMPARTIR / EXPORTAR:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation

AutorRamírez, Belén G.; Blázquez, Cristina; Gómez del Pulgar, Teresa CSIC; Guzmán, Manuel; Ceballos, María L. de CSIC ORCID
Palabras claveAlzheimer's disease
[beta]-amyloid
Cannabinoids
microglia
Fecha de publicación2005
EditorSociety for Neuroscience
CitaciónJ. Neuroscience 25 (8): 1904-1913 (2005)
ResumenAlzheimer's disease (AD) is characterized by enhanced -amyloid peptide (A) deposition along with glial activation in senile plaques, selective neuronal loss, and cognitive deficits. Cannabinoids are neuroprotective agents against excitotoxicity in vitro and acute brain damage in vivo. This background prompted us to study the localization, expression, and function of cannabinoid receptors in AD and the possible protective role of cannabinoids after A treatment, both in vivo and in vitro. Here, we show that senile plaques in AD patients express cannabinoid receptors CB1 and CB2, together with markers of microglial activation, and that CB1-positive neurons, present in high numbers in control cases, are greatly reduced in areas of microglial activation. In pharmacological experiments, we found that G-protein coupling and CB1 receptor protein expression are markedly decreased in AD brains. Additionally, in AD brains, protein nitration is increased, and, more specifically, CB1 and CB2 proteins show enhanced nitration. Intracerebroventricular administration of the synthetic cannabinoid WIN55,212-2 to rats prevent A-induced microglial activation, cognitive impairment, and loss of neuronal markers. Cannabinoids (HU-210, WIN55,212-2, and JWH-133) block A-induced activation of cultured microglial cells, as judged by mitochondrial activity, cell morphology, and tumor necrosis factor-α release; these effects are independent of the antioxidant action of cannabinoid compounds and are also exerted by a CB2-selective agonist. Moreover, cannabinoids abrogate microglia-mediated neurotoxicity after A addition to rat cortical cocultures. Our results indicate that cannabinoid receptors are important in the pathology of AD and that cannabinoids succeed in preventing the neurodegenerative process occurring in the disease.
Descripción10 pages, 7 figures. - PMID: 15728830 [PubMed - indexed for MEDLINE] Free Article
Versión del editorhttp://www.jneurosci.org/content/25/8/1904.long
URIhttp://hdl.handle.net/10261/36473
ISSN0270-6474
E-ISSN1529-2401
Aparece en las colecciones: (IC) Artículos

Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

249
checked on 23-mar-2024

SCOPUSTM   
Citations

674
checked on 29-mar-2024

WEB OF SCIENCETM
Citations

591
checked on 26-feb-2024

Page view(s)

412
checked on 28-mar-2024

Google ScholarTM

Check

Altmetric



NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.